|
ERICH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.10379499879332E-11 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.65467639590133E-12 |
| Stage1-vs-Stage2 |
6.519200E-01 |
| Stage1-vs-Stage3 |
1.703890E-02 |
| Stage1-vs-Stage4 |
3.484600E-01 |
| Stage2-vs-Stage3 |
2.650000E-01 |
| Stage2-vs-Stage4 |
7.379200E-01 |
| Stage3-vs-Stage4 |
4.062800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.64339996955709E-09 |
| Normal-vs-Asian |
3.22310000910875E-09 |
| Caucasian-vs-AfricanAmerican |
2.431400E-01 |
| Caucasian-vs-Asian |
6.741900E-02 |
| AfricanAmerican-vs-Asian |
8.392000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62470037423645E-12 |
| Male-vs-Female |
1.633840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
6.04140000000086E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.176600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.885700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.366400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.475600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.978600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.766600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.039600E-01 |
| Classical-VS-Follicular |
4.404000E-01 |
| Classical-VS-Other |
9.809200E-01 |
| Classical-VS-Normal |
2.70339306496226E-13 |
| Tall-VS-Follicular |
6.843000E-01 |
| Tall-VS-Other |
5.810000E-01 |
| Tall-VS-Normal |
8.60989057827055E-12 |
| Follicular-VS-Other |
7.922400E-01 |
| Follicular-VS-Normal |
1.67066360745594E-12 |
| Other-VS-Normal |
9.829600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
8.97060203897126E-14 |
| N0-vs-N1 |
7.302400E-01 |
|
|
